BA
CRL icon

BlackRock Advisors’s Charles River Laboratories CRL Stock Holding History

BlackRock Advisors’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$2.13M Buy
27,940
+1,700
+6% +$129K ﹤0.01% 1482
2016
Q3 		$2.19M Buy
26,240
+425
+2% +$35.6K ﹤0.01% 1431
2016
Q2 		$2.13M Buy
25,815
+2,156
+9% +$178K ﹤0.01% 1403
2016
Q1 		$1.8M Sell
23,659
-444,082
-95% -$32.9M ﹤0.01% 1468
2015
Q4 		$37.6M Sell
467,741
-878,475
-65% -$63.4M 0.04% 375
2015
Q3 		$85.5M Sell
1,346,216
-5,172
-0.4% -$371K 0.09% 218
2015
Q2 		$95.1M Buy
1,351,388
+44,298
+3% +$3.28M 0.1% 207
2015
Q1 		$104M Buy
1,307,090
+89,100
+7% +$6.57M 0.11% 210
2014
Q4 		$77.5M Buy
1,217,990
+39,400
+3% +$2.47M 0.08% 253
2014
Q3 		$70.4M Sell
1,178,590
-59,397
-5% -$3.4M 0.07% 269
2014
Q2 		$66.3M Sell
1,237,987
-5,700
-0.5% -$313K 0.06% 288
2014
Q1 		$75M Buy
1,243,687
+1,236,297
+16,729% +$72.1M 0.07% 272
2013
Q4 		$392K Buy
7,390
+297
+4% +$14.9K ﹤0.01% 2217
2013
Q3 		$328K Buy
7,093
+80
+1% +$3.67K ﹤0.01% 2216
2013
Q2 		$288K Buy
+7,013
New +$300K ﹤0.01% 2235

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BlackRock Advisors's CRL Position: Q4 2016 in Review

BlackRock Advisors increased its Charles River Laboratories (CRL) stake by 6.5% in Q4 2016, buying an estimated $129K and bringing the position to 27,940 shares worth $2.13M. The position accounts for ﹤0.01% of the portfolio, ranked #1482.

BlackRock Advisors first reported a position in CRL in Q2 2013 and has held it in 15 quarters since. The position peaked at $104M in Q1 2015. 297 funds tracked by Wall St. Rank hold CRL as of Q4 2016.

  • BlackRock Advisors held 27,940 shares of Charles River Laboratories worth $2.13M as of Q4 2016.
  • BlackRock Advisors bought 1,700 Charles River Laboratories shares in Q4 2016, an estimated $129K.
  • Charles River Laboratories made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #1482 holding.
  • BlackRock Advisors first reported a position in Charles River Laboratories in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's Charles River Laboratories position peaked at $104M in Q1 2015.
  • 297 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.